Global IVD Infectious Disease Market Research Report 2023

Report ID: 1986032 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global IVD Infectious Disease Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Biochemical Diagnosis
        1.2.3 Immune Diagnosis
        1.2.4 Molecular Diagnosis
        1.2.5 Microbiological Diagnosis
        1.2.6 Urine Diagnosis
        1.2.7 Coagulation Diagnosis
        1.2.8 Other
    1.3 Market by Application
        1.3.1 Global IVD Infectious Disease Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Personal
        1.3.3 Commercial
        1.3.4 Academic
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global IVD Infectious Disease Market Perspective (2017-2028)
    2.2 IVD Infectious Disease Growth Trends by Region
        2.2.1 IVD Infectious Disease Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 IVD Infectious Disease Historic Market Size by Region (2017-2022)
        2.2.3 IVD Infectious Disease Forecasted Market Size by Region (2023-2028)
    2.3 IVD Infectious Disease Market Dynamics
        2.3.1 IVD Infectious Disease Industry Trends
        2.3.2 IVD Infectious Disease Market Drivers
        2.3.3 IVD Infectious Disease Market Challenges
        2.3.4 IVD Infectious Disease Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top IVD Infectious Disease Players by Revenue
        3.1.1 Global Top IVD Infectious Disease Players by Revenue (2017-2022)
        3.1.2 Global IVD Infectious Disease Revenue Market Share by Players (2017-2022)
    3.2 Global IVD Infectious Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by IVD Infectious Disease Revenue
    3.4 Global IVD Infectious Disease Market Concentration Ratio
        3.4.1 Global IVD Infectious Disease Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Disease Revenue in 2021
    3.5 IVD Infectious Disease Key Players Head office and Area Served
    3.6 Key Players IVD Infectious Disease Product Solution and Service
    3.7 Date of Enter into IVD Infectious Disease Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 IVD Infectious Disease Breakdown Data by Type
    4.1 Global IVD Infectious Disease Historic Market Size by Type (2017-2022)
    4.2 Global IVD Infectious Disease Forecasted Market Size by Type (2023-2028)
5 IVD Infectious Disease Breakdown Data by Application
    5.1 Global IVD Infectious Disease Historic Market Size by Application (2017-2022)
    5.2 Global IVD Infectious Disease Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America IVD Infectious Disease Market Size (2017-2028)
    6.2 North America IVD Infectious Disease Market Size by Country (2017-2022)
    6.3 North America IVD Infectious Disease Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe IVD Infectious Disease Market Size (2017-2028)
    7.2 Europe IVD Infectious Disease Market Size by Country (2017-2022)
    7.3 Europe IVD Infectious Disease Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific IVD Infectious Disease Market Size (2017-2028)
    8.2 Asia-Pacific IVD Infectious Disease Market Size by Country (2017-2022)
    8.3 Asia-Pacific IVD Infectious Disease Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America IVD Infectious Disease Market Size (2017-2028)
    9.2 Latin America IVD Infectious Disease Market Size by Country (2017-2022)
    9.3 Latin America IVD Infectious Disease Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa IVD Infectious Disease Market Size (2017-2028)
    10.2 Middle East & Africa IVD Infectious Disease Market Size by Country (2017-2022)
    10.3 Middle East & Africa IVD Infectious Disease Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Roche Diagnostics
        11.1.1 Roche Diagnostics Company Detail
        11.1.2 Roche Diagnostics Business Overview
        11.1.3 Roche Diagnostics IVD Infectious Disease Introduction
        11.1.4 Roche Diagnostics Revenue in IVD Infectious Disease Business (2017-2022)
        11.1.5 Roche Diagnostics Recent Development
    11.2 Abbott Laboratories
        11.2.1 Abbott Laboratories Company Detail
        11.2.2 Abbott Laboratories Business Overview
        11.2.3 Abbott Laboratories IVD Infectious Disease Introduction
        11.2.4 Abbott Laboratories Revenue in IVD Infectious Disease Business (2017-2022)
        11.2.5 Abbott Laboratories Recent Development
    11.3 Abbott
        11.3.1 Abbott Company Detail
        11.3.2 Abbott Business Overview
        11.3.3 Abbott IVD Infectious Disease Introduction
        11.3.4 Abbott Revenue in IVD Infectious Disease Business (2017-2022)
        11.3.5 Abbott Recent Development
    11.4 Gen-Probe
        11.4.1 Gen-Probe Company Detail
        11.4.2 Gen-Probe Business Overview
        11.4.3 Gen-Probe IVD Infectious Disease Introduction
        11.4.4 Gen-Probe Revenue in IVD Infectious Disease Business (2017-2022)
        11.4.5 Gen-Probe Recent Development
    11.5 Becton Dickinson (BD)
        11.5.1 Becton Dickinson (BD) Company Detail
        11.5.2 Becton Dickinson (BD) Business Overview
        11.5.3 Becton Dickinson (BD) IVD Infectious Disease Introduction
        11.5.4 Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2017-2022)
        11.5.5 Becton Dickinson (BD) Recent Development
    11.6 Bio-Rad Laboratories
        11.6.1 Bio-Rad Laboratories Company Detail
        11.6.2 Bio-Rad Laboratories Business Overview
        11.6.3 Bio-Rad Laboratories IVD Infectious Disease Introduction
        11.6.4 Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2017-2022)
        11.6.5 Bio-Rad Laboratories Recent Development
    11.7 Siemens Healthcare
        11.7.1 Siemens Healthcare Company Detail
        11.7.2 Siemens Healthcare Business Overview
        11.7.3 Siemens Healthcare IVD Infectious Disease Introduction
        11.7.4 Siemens Healthcare Revenue in IVD Infectious Disease Business (2017-2022)
        11.7.5 Siemens Healthcare Recent Development
    11.8 Biomérieux
        11.8.1 Biomérieux Company Detail
        11.8.2 Biomérieux Business Overview
        11.8.3 Biomérieux IVD Infectious Disease Introduction
        11.8.4 Biomérieux Revenue in IVD Infectious Disease Business (2017-2022)
        11.8.5 Biomérieux Recent Development
    11.9 Danaher
        11.9.1 Danaher Company Detail
        11.9.2 Danaher Business Overview
        11.9.3 Danaher IVD Infectious Disease Introduction
        11.9.4 Danaher Revenue in IVD Infectious Disease Business (2017-2022)
        11.9.5 Danaher Recent Development
    11.10 Thermo Fisher
        11.10.1 Thermo Fisher Company Detail
        11.10.2 Thermo Fisher Business Overview
        11.10.3 Thermo Fisher IVD Infectious Disease Introduction
        11.10.4 Thermo Fisher Revenue in IVD Infectious Disease Business (2017-2022)
        11.10.5 Thermo Fisher Recent Development
    11.11 Sysmex
        11.11.1 Sysmex Company Detail
        11.11.2 Sysmex Business Overview
        11.11.3 Sysmex IVD Infectious Disease Introduction
        11.11.4 Sysmex Revenue in IVD Infectious Disease Business (2017-2022)
        11.11.5 Sysmex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global IVD Infectious Disease Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Biochemical Diagnosis
    Table 3. Key Players of Immune Diagnosis
    Table 4. Key Players of Molecular Diagnosis
    Table 5. Key Players of Microbiological Diagnosis
    Table 6. Key Players of Urine Diagnosis
    Table 7. Key Players of Coagulation Diagnosis
    Table 8. Key Players of Other
    Table 9. Global IVD Infectious Disease Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global IVD Infectious Disease Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global IVD Infectious Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global IVD Infectious Disease Market Share by Region (2017-2022)
    Table 13. Global IVD Infectious Disease Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global IVD Infectious Disease Market Share by Region (2023-2028)
    Table 15. IVD Infectious Disease Market Trends
    Table 16. IVD Infectious Disease Market Drivers
    Table 17. IVD Infectious Disease Market Challenges
    Table 18. IVD Infectious Disease Market Restraints
    Table 19. Global IVD Infectious Disease Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global IVD Infectious Disease Market Share by Players (2017-2022)
    Table 21. Global Top IVD Infectious Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Disease as of 2021)
    Table 22. Ranking of Global Top IVD Infectious Disease Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by IVD Infectious Disease Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players IVD Infectious Disease Product Solution and Service
    Table 26. Date of Enter into IVD Infectious Disease Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global IVD Infectious Disease Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global IVD Infectious Disease Revenue Market Share by Type (2017-2022)
    Table 30. Global IVD Infectious Disease Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global IVD Infectious Disease Revenue Market Share by Type (2023-2028)
    Table 32. Global IVD Infectious Disease Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global IVD Infectious Disease Revenue Market Share by Application (2017-2022)
    Table 34. Global IVD Infectious Disease Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global IVD Infectious Disease Revenue Market Share by Application (2023-2028)
    Table 36. North America IVD Infectious Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America IVD Infectious Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe IVD Infectious Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Europe IVD Infectious Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Asia-Pacific IVD Infectious Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 41. Asia-Pacific IVD Infectious Disease Market Size by Region (2023-2028) & (US$ Million)
    Table 42. Latin America IVD Infectious Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Latin America IVD Infectious Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Middle East & Africa IVD Infectious Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Middle East & Africa IVD Infectious Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Roche Diagnostics Company Detail
    Table 47. Roche Diagnostics Business Overview
    Table 48. Roche Diagnostics IVD Infectious Disease Product
    Table 49. Roche Diagnostics Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 50. Roche Diagnostics Recent Development
    Table 51. Abbott Laboratories Company Detail
    Table 52. Abbott Laboratories Business Overview
    Table 53. Abbott Laboratories IVD Infectious Disease Product
    Table 54. Abbott Laboratories Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 55. Abbott Laboratories Recent Development
    Table 56. Abbott Company Detail
    Table 57. Abbott Business Overview
    Table 58. Abbott IVD Infectious Disease Product
    Table 59. Abbott Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 60. Abbott Recent Development
    Table 61. Gen-Probe Company Detail
    Table 62. Gen-Probe Business Overview
    Table 63. Gen-Probe IVD Infectious Disease Product
    Table 64. Gen-Probe Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 65. Gen-Probe Recent Development
    Table 66. Becton Dickinson (BD) Company Detail
    Table 67. Becton Dickinson (BD) Business Overview
    Table 68. Becton Dickinson (BD) IVD Infectious Disease Product
    Table 69. Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 70. Becton Dickinson (BD) Recent Development
    Table 71. Bio-Rad Laboratories Company Detail
    Table 72. Bio-Rad Laboratories Business Overview
    Table 73. Bio-Rad Laboratories IVD Infectious Disease Product
    Table 74. Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 75. Bio-Rad Laboratories Recent Development
    Table 76. Siemens Healthcare Company Detail
    Table 77. Siemens Healthcare Business Overview
    Table 78. Siemens Healthcare IVD Infectious Disease Product
    Table 79. Siemens Healthcare Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 80. Siemens Healthcare Recent Development
    Table 81. Biomérieux Company Detail
    Table 82. Biomérieux Business Overview
    Table 83. Biomérieux IVD Infectious Disease Product
    Table 84. Biomérieux Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 85. Biomérieux Recent Development
    Table 86. Danaher Company Detail
    Table 87. Danaher Business Overview
    Table 88. Danaher IVD Infectious Disease Product
    Table 89. Danaher Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 90. Danaher Recent Development
    Table 91. Thermo Fisher Company Detail
    Table 92. Thermo Fisher Business Overview
    Table 93. Thermo Fisher IVD Infectious Disease Product
    Table 94. Thermo Fisher Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 95. Thermo Fisher Recent Development
    Table 96. Sysmex Company Detail
    Table 97. Sysmex Business Overview
    Table 98. Sysmex IVD Infectious DiseaseProduct
    Table 99. Sysmex Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 100. Sysmex Recent Development
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global IVD Infectious Disease Market Share by Type: 2021 VS 2028
    Figure 2. Biochemical Diagnosis Features
    Figure 3. Immune Diagnosis Features
    Figure 4. Molecular Diagnosis Features
    Figure 5. Microbiological Diagnosis Features
    Figure 6. Urine Diagnosis Features
    Figure 7. Coagulation Diagnosis Features
    Figure 8. Other Features
    Figure 9. Global IVD Infectious Disease Market Share by Application in 2021 & 2028
    Figure 10. Personal Case Studies
    Figure 11. Commercial Case Studies
    Figure 12. Academic Case Studies
    Figure 13. Other Case Studies
    Figure 14. IVD Infectious Disease Report Years Considered
    Figure 15. Global IVD Infectious Disease Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global IVD Infectious Disease Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global IVD Infectious Disease Market Share by Region: 2021 VS 2028
    Figure 18. Global IVD Infectious Disease Market Share by Players in 2021
    Figure 19. Global Top IVD Infectious Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Disease as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by IVD Infectious Disease Revenue in 2021
    Figure 21. North America IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. North America IVD Infectious Disease Market Share by Country (2017-2028)
    Figure 23. United States IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe IVD Infectious Disease Market Share by Country (2017-2028)
    Figure 27. Germany IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific IVD Infectious Disease Market Share by Region (2017-2028)
    Figure 35. China IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America IVD Infectious Disease Market Share by Country (2017-2028)
    Figure 43. Mexico IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Brazil IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa IVD Infectious Disease Market Share by Country (2017-2028)
    Figure 47. Turkey IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Saudi Arabia IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Roche Diagnostics Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 50. Abbott Laboratories Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 51. Abbott Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 52. Gen-Probe Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 53. Becton Dickinson (BD) Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 54. Bio-Rad Laboratories Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 55. Siemens Healthcare Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 56. Biomérieux Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 57. Danaher Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 58. Thermo Fisher Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 59. Sysmex Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche Diagnostics
Abbott Laboratories
Abbott
Gen-Probe
Becton Dickinson (BD)
Bio-Rad Laboratories
Siemens Healthcare
Biomérieux
Danaher
Thermo Fisher
Sysmex
Frequently Asked Questions
IVD Infectious Disease report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
IVD Infectious Disease report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
IVD Infectious Disease report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports